Bioproduction des immunothérapies en France

27-09-2017

Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generation of RNA delivery particle and its applications in gene editing and immunotherapy.
Bioproduction des immunothérapies en France

This event has been organized by MabDesign and Medicen, in partnership with France Biotech. More about this conference on https://www.b2match.eu/bioproductionimmunotherapies.